Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Asset Writedowns and Impairment (2016)

Amphastar Pharmaceuticals has reported Asset Writedowns and Impairment over the past 4 years, most recently at $114000.0 for Q2 2016.

  • For Q2 2016, Asset Writedowns and Impairment changed N/A year-over-year to $114000.0; the TTM value through Dec 2023 reached $114000.0, changed N/A, while the annual FY2023 figure was $2.7 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q2 2016 was $114000.0 at Amphastar Pharmaceuticals, down from $217000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $217000.0 in Q1 2016 and troughed at $4000.0 in Q3 2015.
  • A 4-year average of $113555.6 and a median of $120000.0 in 2013 define the central range for Asset Writedowns and Impairment.
  • On a YoY basis, Asset Writedowns and Impairment climbed as much as 64.1% in 2015 and fell as far as 69.23% in 2015.
  • Year by year, Asset Writedowns and Impairment stood at $120000.0 in 2013, then tumbled by 35.0% to $78000.0 in 2014, then surged by 64.1% to $128000.0 in 2015, then dropped by 10.94% to $114000.0 in 2016.
  • Business Quant data shows Asset Writedowns and Impairment for AMPH at $114000.0 in Q2 2016, $217000.0 in Q1 2016, and $128000.0 in Q4 2015.